Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochemical Pharmacology

• Publication date

  1994-05-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(94)90304-2PMID 8204093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques.

  1993cited by this paper
• Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.

  1993cited by this paper
• Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.

  1993cited by this paper
• Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism.

  1993cited by this paper
• Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.

  1992cited by this paper
• Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

  1992cited by this paper
• Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms.

  1992cited by this paper
• Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.

  1991cited by this paper
• Measurement of cytochrome P450 activation of xenobiotics using the Ames Salmonella test.

  1991cited by this paper
• Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.

  1991cited by this paper
• Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization

  1991cited by this paper
• Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects.

  1991cited by this paper
• Characterization of roles of human cytochrome P-450 enzymes in carcinogen metabolism

  1990cited by this paper
• Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.

  1990cited by this paper
• Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

  1990cited by this paper
• Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

  1989cited by this paper
• Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450.

  1989cited by this paper
• Theophylline Metabolism by Human, Rabbit and Rat Liver Microsomes and by Purified Forms of Cytochrome P450

  1988cited by this paper
• Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies.

  1988cited by this paper
• Biotransformation of caffeine by microsomes from human liver. Kinetics and inhibition studies.

  1987cited by this paper
• Quantitative assessment of caffeine partial clearances in man.

  1986cited by this paper
• INVERTED RESPONSE OF ARGININE VASOPRESSIN TO POSTURAL CHANGE IN PATIENTS WITH ESSENTIAL HYPERTENSION

  1982cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Design and Synthesis of Caffeine-Based Derivatives with Antioxidant and Neuroprotective Activity: In Vitro Evaluation and SwissADME Profiling.

  2026cites this paper
• Alteration of Antioxidant and Xenobiotic Metabolizing Enzyme Activities in Rainbow Trout (Oncorhynchus mykiss) Treated With Caffeine and Cotinine During the Spawning Season

  2025cites this paper
• Use of Extracorporeal Therapies to Treat Severe Caffeine Poisoning

  2025cites this paper
• Elucidating the Substrate Specificity of Cytochrome P450 Enzymes: Insights into N- and S-Containing Small-Molecule Metabolism

  2025cites this paper
• Changes in the Fraction Metabolized in Children Younger than Four Years; When is Clearance Scaling for the Dominant Elimination Route in Adults Appropriate?

  2025cites this paper
• Multi-omics revealed the effects of dietary energy levels on the rumen microbiota and metabolites in yaks under house-feeding conditions

  2024cites this paper
• Human metabolome variation along the upper intestinal tract

  2023cites this paper
• Exploring Partial Structural Disorder in Anhydrous Paraxanthine through Combined Experiment, Solid-State Computational Modelling, and Molecular Docking

  2023cites this paper
• The safety of oral antifungals for the treatment of onychomycosis

  2023cites this paper
• CYP1A inhibitors: Recent progress, current challenges, and future perspectives

  2023cites this paper
• Single Mutations in Cytochrome P450 Oxidoreductase Can Alter the Specificity of Human Cytochrome P450 1A2-Mediated Caffeine Metabolism

  2023cites this paper
• Determination of temporal changes in hepatic drug-oxidizing capacity using plasma metabolite/caffeine ratios in non-pregnant and pregnant goats.

  2023cites this paper
• CYP1A2-Mediated Pharmacokinetic Interaction of Caffeine and Theophylline in Mice

  2023cites this paper
• Voltammetric Responses of a CYP2D6‐Based Biosensor to 3,4‐methylenedioxymethamphetamine (MDMA) and the Synthetic Cathinone α‐pyrrolidinopentiophenone (α‐PVP).

  2022cites this paper
• Modulatory Effects of Citrus Flavonoids Towards the Metabolism and Mutagenicity of Environmental Carcinogens

  2022cites this paper
• Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms.

  2022cites this paper
• The synergistic effect of sea cucumber saponins and caffeine on preventing obesity in high-fat diet-fed mice by extending the action duration of caffeine.

  2022cites this paper
• Caffeine improves the cytotoxic effect of dacarbazine on B16F10 murine melanoma cells.

  2021cites this paper
• In silico screening and analysis of nonsynonymous SNPs in human CYP1A2 to assess possible associations with pathogenicity and cancer susceptibility

  2021cites this paper
• Response differences of HepG2 and Primary Mouse Hepatocytes to morphological changes in electrospun PCL scaffolds

  2021cites this paper
• Parkinson’s Disease: An Overview of Various Treatments

  2020cites this paper
• No significant effect of caffeine on five kilometer running performance after muscle damage.

  2020cites this paper
• Design and development of a proniosomal transdermal drug delivery system of caffeine for management of migraine: In vitro characterization, 131I-radiolabeling and in vivo biodistribution studies

  2020cites this paper
• Tea and coffee consumption and pathophysiology related to kidney stone formation: a systematic review

  2020cites this paper
• Is there a sex difference in adult salivary clearance of caffeine (1,3,7-trimethylpurine-2,6-dione)?

  2020cites this paper
• Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring

  2020cites this paper
• X (metal: Al, Cu, Sn, Ti)-functionalized tunable 2D-MoS2 nanostructure assembled biosensor arrays for qualitative and quantitative analysis of vital neurological drugs.

  2020cites this paper
• Biochemical Aspects of the Hepatic Microsomal Ethanol-oxidizing System (MEOS): Resolved Initial Controversies and Updated Molecular Views

  2019cites this paper
• Microsomal Ethanol‐Oxidizing System: Success Over 50 Years and an Encouraging Future

  2019cites this paper
• Phe-125 and Phe-226 of pig cytochrome P450 1A2 stabilize the binding of aflatoxin B1 and 7-ethoxyresorufin through the key CH/π interactions.

  2019cites this paper
• Caffeine metabolite as a biomarker in carbon tetrachloride-induced hepatotoxicity in rats

  2019cites this paper
• Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity

  2019cites this paper
• A Retrospective Study on the Epidemiological and Clinical Features of Emergency Patients with Large or Massive Consumption of Caffeinated Supplements or Energy Drinks in Japan

  2018cites this paper
• Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2‐ and CYP3A4‐selective Inhibitors

  2018cites this paper
• Can pancreatitis be treated by inhibiting Ca2+ signaling?

  2018cites this paper
• Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease

  2018cites this paper
• Caffeine in Kidney Stone Disease: Risk or Benefit?

  2018cites this paper
• Chapter 1 Introductory Chapter : Caffeine , a Major Component of Nectar of the Gods and Favourite Beverage of Kings , Popes , Artists and Revolutionists , a Drug or a Poison ?

  2018cites this paper
• In silico prediction of potential chemical reactions mediated by human enzymes

  2018cites this paper
• Role of Caffeine in Sports Nutrition

  2017cites this paper
• Methylxanthines: Dietary Sources, Bioavailability, and Health Benefits

  2017cites this paper
• Awareness of consuming caffeine in pregnant women

  2017cites this paper
• Fast and robust detection of ancestral selective sweeps

  2017cites this paper
• The neuroprotective effects of caffeine in neurodegenerative diseases

  2017cites this paper
• Cigarette smoking and heavy coffee drinking affect therapeutic response to olanzapine

  2017cites this paper
• Endothelial Nitric Oxide Mediates Caffeine Antagonism of Alcohol-Induced Cerebral Artery Constriction

  2016cites this paper
• Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach.

  2016cites this paper
• Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice

  2016cites this paper
• CHARLES UNIVERSITY OF PRAGUE FACULTY OF SCIENCE DEPARTMENT OF BIOCHEMISTRY Počítačové modelování interakcí typu enzym-substrát, pomocí programu AutoDock 4 Computer modeling of enzyme-ligand interactions using software package AutoDock 4

  2016cites this paper
• The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.

  2016cites this paper
• Caffeine metabolism rate influences coffee perception, preferences and intake

  2016cites this paper
• Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs

  2016cites this paper
• Meta‐analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

  2016cites this paper
• Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine

  2016cites this paper
• The Role of Coffee in the Therapy of Parkinson's Disease

  2015cites this paper
• Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies

  2015cites this paper
• The Effects of Bovine Serum Albumin on Kinetic Characterization of Human Liver Microsomal CYP2C19 and CYP2E1 Activities

  2015cites this paper
• Pharmacokinetics of oral caffeine in sows: a pilot study.

  2015cites this paper
• The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice.

  2015cites this paper
• Caffeine in Coffee

  2015cites this paper
• THE EFFECT OF CYP 1 A 2 GENE VARIANTS AND CAFFEINE ON RATINGS OF PERCEIVED EXERTION

  2014influential citation
• Pharmacokinetics of Lacosamide and Omeprazole Coadministration in Healthy Volunteers: Results from a Phase I, Randomized, Crossover Trial

  2014cites this paper
• Rôle des Cytochromes P450 dans la perception sensorielle et le métabolisme de la caféine chez Drosophila melanogaster

  2014cites this paper
• Predicting In Vivo Caffeine/ Angelica dahurica and Caffeine/ Salvia miltiorrhiza Pharmacokinetic Interactions in Humans with In Vitro CYP1A2 Inhibition Data

  2014cites this paper
• High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the Norwegian Women and Cancer Study: a population-based prospective study

  2014cites this paper
• Caffeine intoxication successfully treated by hemoperfusion and hemodialysis.

  2014cites this paper
• Protective effects of coffee against induction of DNA damage and pre-neoplastic foci by aflatoxin B₁.

  2014cites this paper
• Mechanism and Catalytic Diversity of Rieske Non-Heme Iron-Dependent Oxygenases.

  2013cites this paper
• A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity

  2013cites this paper
• Caffeine intake and the plasma proteome

  2013cites this paper
• Cocoa and human health.

  2013cites this paper
• A. Genetic characterization of the caffeine C-8 oxidation pathway in Pseudomonas Sp. CBB1 B. Validation of caffeine dehydrogenase as a suitable enzyme for a rapid caffeine diagnostic test

  2013cites this paper
• Exceptional Case Haemodialysis in massive caffeine intoxication

  2012cites this paper
• Paracetamol metabolism in postoperative patients

  2012cites this paper
• Haemodialysis in massive caffeine intoxication

  2012cites this paper
• Measurement of CYP1A2 activity: a focus on caffeine as a probe.

  2012cites this paper
• Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats

  2012cites this paper
• Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance

  2012cites this paper
• Topics on Drug Metabolism

  2012cites this paper
• Determination of Cytochrome P450 Metabolic Activity Using Selective Markers

  2012cites this paper
• New Specific Marker of Cytochrome P450 1A2 Activity

  2011cites this paper
• Measurements of caffeine and plasma metabolite/caffeine ratios as a test for hepatic drug-oxidizing capacity in goats

  2011cites this paper
• Determinants of Cognitive Impairment in Old Age and Their Genetic Architecture

  2011cites this paper
• Pharmacokinetics and metabolism of natural methylxanthines in animal and man.

  2011cites this paper
• Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition.

  2011cites this paper
• Comparative pharmacokinetics and metabolisms of caffeine in sheep breeds.

  2011cites this paper
• Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics

  2011cites this paper
• Metabolism, enzymology, and genetic characterization of caffeine degradation by pseudomonas putida CBB5

  2011influential citation
• Genetic Modifiers of Caffeine Consumption and Risk of Myocardial Infarction

  2011cites this paper
• In vitro–in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance

  2011cites this paper
• Caffeine challenge test and panic disorder: a systematic literature review

  2011cites this paper
• Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order

  2011cites this paper
• Australian Public Assessment Report for Caffeine citrate

  2011cites this paper
• Molecular characterisation of glycine–N–acyltransferase from two primates : the vervet monkey and the chacma baboon

  2011cites this paper
• Characterization of a broad-specificity non-haem iron N-demethylase from Pseudomonas putida CBB5 capable of utilizing several purine alkaloids as sole carbon and nitrogen source.

  2011influential citation
• Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene ω-hydroxylase CYP4C7

  2010cites this paper
• Maternal Caffeine Consumption and its Relationship to Adverse Pregnancy Outcomes

  2010influential citation
• Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2

  2010cites this paper
• Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.

  2010cites this paper
• Fast Prediction of Cytochrome P450 Mediated Drug Metabolism

  2009cites this paper